219 related articles for article (PubMed ID: 12269822)
1. Roles of specific extracellular domains of the glucagon receptor in ligand binding and signaling.
Unson CG; Wu CR; Jiang Y; Yoo B; Cheung C; Sakmar TP; Merrifield RB
Biochemistry; 2002 Oct; 41(39):11795-803. PubMed ID: 12269822
[TBL] [Abstract][Full Text] [Related]
2. Analysis of parathyroid hormone (PTH)/secretin receptor chimeras differentiates the role of functional domains in the pth/ pth-related peptide (PTHrP) receptor on hormone binding and receptor activation.
Vilardaga JP; Lin I; Nissenson RA
Mol Endocrinol; 2001 Jul; 15(7):1186-99. PubMed ID: 11435617
[TBL] [Abstract][Full Text] [Related]
3. Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity.
Runge S; Wulff BS; Madsen K; Bräuner-Osborne H; Knudsen LB
Br J Pharmacol; 2003 Mar; 138(5):787-94. PubMed ID: 12642379
[TBL] [Abstract][Full Text] [Related]
4. The amino terminal domain of the glucagon-like peptide-1 receptor is a critical determinant of subtype specificity.
Graziano MP; Hey PJ; Strader CD
Recept Channels; 1996; 4(1):9-17. PubMed ID: 8723643
[TBL] [Abstract][Full Text] [Related]
5. Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding.
Unson CG; Cypess AM; Wu CR; Goldsmith PK; Merrifield RB; Sakmar TP
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):310-5. PubMed ID: 8552628
[TBL] [Abstract][Full Text] [Related]
6. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
7. A model for receptor-peptide binding at the glucagon-like peptide-1 (GLP-1) receptor through the analysis of truncated ligands and receptors.
Al-Sabah S; Donnelly D
Br J Pharmacol; 2003 Sep; 140(2):339-46. PubMed ID: 12970080
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a region of the lutropin receptor extracellular domain near transmembrane helix 1 that is important in ligand-mediated signaling.
Alvarez CA; Narayan P; Huang J; Puett D
Endocrinology; 1999 Apr; 140(4):1775-82. PubMed ID: 10098515
[TBL] [Abstract][Full Text] [Related]
9. Characterization of deletion and truncation mutants of the rat glucagon receptor. Seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding.
Unson CG; Cypess AM; Kim HN; Goldsmith PK; Carruthers CJ; Merrifield RB; Sakmar TP
J Biol Chem; 1995 Nov; 270(46):27720-7. PubMed ID: 7499239
[TBL] [Abstract][Full Text] [Related]
10. Characterization of glucagon-like peptide-1 receptor-binding determinants.
Xiao Q; Jeng W; Wheeler MB
J Mol Endocrinol; 2000 Dec; 25(3):321-35. PubMed ID: 11116211
[TBL] [Abstract][Full Text] [Related]
11. Glucagon.glucagon-like peptide I receptor chimeras reveal domains that determine specificity of glucagon binding.
Buggy JJ; Livingston JN; Rabin DU; Yoo-Warren H
J Biol Chem; 1995 Mar; 270(13):7474-8. PubMed ID: 7706293
[TBL] [Abstract][Full Text] [Related]
12. Differential Requirement of the Extracellular Domain in Activation of Class B G Protein-coupled Receptors.
Zhao LH; Yin Y; Yang D; Liu B; Hou L; Wang X; Pal K; Jiang Y; Feng Y; Cai X; Dai A; Liu M; Wang MW; Melcher K; Xu HE
J Biol Chem; 2016 Jul; 291(29):15119-30. PubMed ID: 27226600
[TBL] [Abstract][Full Text] [Related]
13. The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1.
López de Maturana R; Willshaw A; Kuntzsch A; Rudolph R; Donnelly D
J Biol Chem; 2003 Mar; 278(12):10195-200. PubMed ID: 12524435
[TBL] [Abstract][Full Text] [Related]
14. Residues within the transmembrane domain of the glucagon-like peptide-1 receptor involved in ligand binding and receptor activation: modelling the ligand-bound receptor.
Coopman K; Wallis R; Robb G; Brown AJ; Wilkinson GF; Timms D; Willars GB
Mol Endocrinol; 2011 Oct; 25(10):1804-18. PubMed ID: 21868452
[TBL] [Abstract][Full Text] [Related]
15. Glucagon-induced self-association of recombinant proteins in Escherichia coli and affinity purification using a fragment of glucagon receptor.
Kim DY; Lee J; Saraswat V; Park YH
Biotechnol Bioeng; 2000 Aug; 69(4):418-28. PubMed ID: 10862680
[TBL] [Abstract][Full Text] [Related]
16. Rearrangement of a polar core provides a conserved mechanism for constitutive activation of class B G protein-coupled receptors.
Yin Y; de Waal PW; He Y; Zhao LH; Yang D; Cai X; Jiang Y; Melcher K; Wang MW; Xu HE
J Biol Chem; 2017 Jun; 292(24):9865-9881. PubMed ID: 28356352
[TBL] [Abstract][Full Text] [Related]
17. The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity.
Wilmen A; Göke B; Göke R
FEBS Lett; 1996 Nov; 398(1):43-7. PubMed ID: 8946950
[TBL] [Abstract][Full Text] [Related]
18. Two cytoplasmic loops of the glucagon receptor are required to elevate cAMP or intracellular calcium.
Cypess AM; Unson CG; Wu CR; Sakmar TP
J Biol Chem; 1999 Jul; 274(27):19455-64. PubMed ID: 10383462
[TBL] [Abstract][Full Text] [Related]
19. Five out of six tryptophan residues in the N-terminal extracellular domain of the rat GLP-1 receptor are essential for its ability to bind GLP-1.
Wilmen A; Van Eyll B; Göke B; Göke R
Peptides; 1997; 18(2):301-5. PubMed ID: 9149304
[TBL] [Abstract][Full Text] [Related]
20. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
